Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|August 16, 2006
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerG P Stathopoulos, K Syrigos, G Aravantinos, et al.
Human Mutation|December 26, 2001
BRCA2 gene mutations in Greek patients with familial breast cancerAthanasios Armakolas, Angela Ladopoulou, Irene Konstantopoulou, et al.
Anticancer Research|April 20, 2006
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II studyJ Dimitroulis, M Toubis, D Antoniou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trialG P Stathopoulos, D Antoniou, J Dimitroulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyG Aravantinos, G Fountzilas, P Kosmidis, et al.
Anti-Cancer Drugs|May 29, 2004
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)Jim Janinis, George P Stathopoulos, Pavlos Nikolaidis, et al.
Plos One|August 11, 2012
Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomesMarta Dueñas, Mirentxu Santos, Juan F Aranda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trialG P Stathopoulos, M Veslemes, N Georgatou, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyGerasimos Aravantinos, George Fountzilas, Aristotelis Bamias, et al.
Breast Cancer Research and Treatment|December 22, 2011
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III TrialHelen Gogas, Urania Dafni, Maria Karina, et al.
Pageof 15